Earnings Preview: Krispy Kreme (DNUT) Q3 Earnings Expected to Decline — Negative
DNUT Zacks Investment Research — October 30, 2025Krispy Kreme (DNUT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Doximity (DOCS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Positive
DOCS Zacks Investment Research — October 30, 2025Doximity (DOCS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
DraftKings (DKNG) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release — Negative
DKNG Zacks Investment Research — October 30, 2025DraftKings (DKNG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Expedia (EXPE) Reports Next Week: Wall Street Expects Earnings Growth — Positive
EXPE Zacks Investment Research — October 30, 2025Expedia (EXPE) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Adherex Technologies Inc. (FENC) May Report Negative Earnings: Know the Trend Ahead of Q3 Release — Negative
FENC Zacks Investment Research — October 30, 2025Adherex Technologies (FENC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Epam (EPAM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release — Positive
EPAM Zacks Investment Research — October 30, 2025Epam (EPAM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Golden Entertainment (GDEN) Q3 Earnings Expected to Decline — Negative
GDEN Zacks Investment Research — October 30, 2025Golden Entertainment (GDEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Globus Medical (GMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release — Positive
GMED Zacks Investment Research — October 30, 2025Globus Medical (GMED) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Canada Goose (GOOS) Q2 Earnings Expected to Decline — Negative
GOOS Zacks Investment Research — October 30, 2025Canada Goose (GOOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Shift4 Payments (FOUR) Reports Next Week: Wall Street Expects Earnings Growth — Positive
FOUR Zacks Investment Research — October 30, 2025Shift4 Payments (FOUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
IREN Limited (IREN) Reports Next Week: Wall Street Expects Earnings Growth — Positive
IREN Zacks Investment Research — October 30, 2025IREN Limited (IREN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kura Sushi (KRUS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release — Neutral
KRUS Zacks Investment Research — October 30, 2025Kura Sushi (KRUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate International Seaways (INSW) to Report a Decline in Earnings: What to Look Out for — Negative
INSW Zacks Investment Research — October 30, 2025International Seaways (INSW) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Bloomin' Brands (BLMN) Q3 Earnings Expected to Decline — Negative
BLMN Zacks Investment Research — October 30, 2025Bloomin' Brands (BLMN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CarGurus (CARG) Reports Next Week: Wall Street Expects Earnings Growth — Positive
CARG Zacks Investment Research — October 30, 2025CarGurus (CARG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Certara, Inc. (CERT) to Report a Decline in Earnings: What to Look Out for — Negative
CERT Zacks Investment Research — October 30, 2025Certara (CERT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BILL Holdings (BILL) Expected to Beat Earnings Estimates: Should You Buy? — Positive
BILL Zacks Investment Research — October 30, 2025BILL Holdings (BILL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Century Casinos (CNTY) Q3 Earnings Expected to Decline — Negative
CNTY Zacks Investment Research — October 30, 2025Century Casinos (CNTY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: Should You Buy? — Neutral
COLL Zacks Investment Research — October 30, 2025Collegium Pharmaceutical (COLL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Civitas Resources (CIVI) Q3 Earnings Expected to Decline — Negative
CIVI Zacks Investment Research — October 30, 2025Civitas (CIVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
